chr16-23607914-A-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_024675.4(PALB2):​c.3300T>G​(p.Thr1100Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0277 in 1,614,080 control chromosomes in the GnomAD database, including 732 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. T1100T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.025 ( 72 hom., cov: 31)
Exomes 𝑓: 0.028 ( 660 hom. )

Consequence

PALB2
NM_024675.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:24

Conservation

PhyloP100: 0.305

Publications

30 publications found
Variant links:
Genes affected
PALB2 (HGNC:26144): (partner and localizer of BRCA2) This gene encodes a protein that may function in tumor suppression. This protein binds to and colocalizes with the breast cancer 2 early onset protein (BRCA2) in nuclear foci and likely permits the stable intranuclear localization and accumulation of BRCA2. [provided by RefSeq, Jul 2008]
PALB2 Gene-Disease associations (from GenCC):
  • hereditary breast carcinoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
  • PALB2-related cancer predisposition
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • Fanconi anemia complementation group N
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen, G2P
  • pancreatic cancer, susceptibility to, 3
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • Fanconi anemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 16-23607914-A-C is Benign according to our data. Variant chr16-23607914-A-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 126730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.305 with no splicing effect.
BA1
GnomAdExome4 highest subpopulation (MID) allele frequency at 95% confidence interval = 0.0558 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_024675.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PALB2
NM_024675.4
MANE Select
c.3300T>Gp.Thr1100Thr
synonymous
Exon 12 of 13NP_078951.2
PALB2
NM_001407296.1
c.3240T>Gp.Thr1080Thr
synonymous
Exon 11 of 12NP_001394225.1
PALB2
NM_001407297.1
c.3228T>Gp.Thr1076Thr
synonymous
Exon 11 of 12NP_001394226.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PALB2
ENST00000261584.9
TSL:1 MANE Select
c.3300T>Gp.Thr1100Thr
synonymous
Exon 12 of 13ENSP00000261584.4Q86YC2
PALB2
ENST00000568219.5
TSL:1
c.2415T>Gp.Thr805Thr
synonymous
Exon 12 of 13ENSP00000454703.2H3BN63
PALB2
ENST00000561514.3
TSL:5
c.3306T>Gp.Thr1102Thr
synonymous
Exon 12 of 13ENSP00000460666.3A0AA52I2C1

Frequencies

GnomAD3 genomes
AF:
0.0254
AC:
3870
AN:
152138
Hom.:
72
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0173
Gnomad AMI
AF:
0.154
Gnomad AMR
AF:
0.0269
Gnomad ASJ
AF:
0.0464
Gnomad EAS
AF:
0.000962
Gnomad SAS
AF:
0.0240
Gnomad FIN
AF:
0.0180
Gnomad MID
AF:
0.0918
Gnomad NFE
AF:
0.0299
Gnomad OTH
AF:
0.0321
GnomAD2 exomes
AF:
0.0237
AC:
5950
AN:
251488
AF XY:
0.0248
show subpopulations
Gnomad AFR exome
AF:
0.0169
Gnomad AMR exome
AF:
0.0163
Gnomad ASJ exome
AF:
0.0351
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.0199
Gnomad NFE exome
AF:
0.0293
Gnomad OTH exome
AF:
0.0293
GnomAD4 exome
AF:
0.0279
AC:
40855
AN:
1461824
Hom.:
660
Cov.:
32
AF XY:
0.0282
AC XY:
20473
AN XY:
727224
show subpopulations
African (AFR)
AF:
0.0165
AC:
551
AN:
33476
American (AMR)
AF:
0.0175
AC:
781
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.0357
AC:
932
AN:
26134
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39700
South Asian (SAS)
AF:
0.0258
AC:
2228
AN:
86254
European-Finnish (FIN)
AF:
0.0195
AC:
1044
AN:
53420
Middle Eastern (MID)
AF:
0.0610
AC:
352
AN:
5766
European-Non Finnish (NFE)
AF:
0.0299
AC:
33267
AN:
1111966
Other (OTH)
AF:
0.0281
AC:
1697
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
2202
4404
6607
8809
11011
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1226
2452
3678
4904
6130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0254
AC:
3865
AN:
152256
Hom.:
72
Cov.:
31
AF XY:
0.0253
AC XY:
1885
AN XY:
74444
show subpopulations
African (AFR)
AF:
0.0172
AC:
716
AN:
41560
American (AMR)
AF:
0.0268
AC:
410
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.0464
AC:
161
AN:
3472
East Asian (EAS)
AF:
0.000965
AC:
5
AN:
5184
South Asian (SAS)
AF:
0.0239
AC:
115
AN:
4820
European-Finnish (FIN)
AF:
0.0180
AC:
191
AN:
10608
Middle Eastern (MID)
AF:
0.0884
AC:
26
AN:
294
European-Non Finnish (NFE)
AF:
0.0299
AC:
2034
AN:
68014
Other (OTH)
AF:
0.0318
AC:
67
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
195
389
584
778
973
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0266
Hom.:
40
Bravo
AF:
0.0260
Asia WGS
AF:
0.00779
AC:
28
AN:
3478
EpiCase
AF:
0.0389
EpiControl
AF:
0.0363

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
6
not specified (6)
-
-
5
Hereditary cancer-predisposing syndrome (5)
-
-
5
not provided (5)
-
-
3
Familial cancer of breast (3)
-
-
1
Breast-ovarian cancer, familial, susceptibility to, 5 (1)
-
-
1
Familial cancer of breast;C1835817:Fanconi anemia complementation group N;C3150547:Pancreatic cancer, susceptibility to, 3 (1)
-
-
1
Fanconi anemia complementation group N (1)
-
-
1
Hereditary breast ovarian cancer syndrome (1)
-
-
1
Malignant tumor of breast (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
2.0
DANN
Benign
0.64
PhyloP100
0.30
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs45516100; hg19: chr16-23619235; API